May Measurement Month 2021: an analysis of blood pressure screening results from Nigeria
Author(s)
Type
Journal Article
Abstract
There is a need to constantly assess the awareness, treatment, and control of hypertension in Nigeria. This study determined the frequency of undiagnosed hypertension across the six geopolitical zones of Nigeria. We conducted an opportunistic screening of adults aged at least 18 years in the month of May 2021. Participants were recruited by trained volunteers using the May Measurement Month protocol. Blood pressure (BP) was measured using validated digital sphygmomanometers. We defined hypertension as systolic BP ≥ 140 and/or diastolic BP ≥ 90 mmHg and/or the use of BP-lowering medications. A total of 9361 participants (51.5% females) with a mean age of 40.7 ± 15.5 years were screened. Hypertension was present in 3192 (34.1%) of the participants. About half (1491, 46.7%) of the hypertensives were unaware of the diagnosis. Among the 3192 participants with hypertension, less than half (1540, 48.2%) were on antihypertensive medications, while only 36.4% of those on antihypertensive medications had their BP controlled (<140/90 mmHg). About one-third of Nigerians in this opportunistic screening had hypertension, with about half of them being unaware of their diagnosis while only about two out of every five on antihypertensive medications had controlled BP. Urgent health actions are needed in Nigeria to reduce the burden of hypertension and its complications.
Date Issued
2024-06
Date Acceptance
2024-07-01
Citation
European Heart Journal Supplements, 2024, 26 (Supplement 3), pp.iii65-iii67
ISSN
1520-765X
Publisher
Oxford University Press
Start Page
iii65
End Page
iii67
Journal / Book Title
European Heart Journal Supplements
Volume
26
Issue
Supplement 3
Copyright Statement
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for
reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for
further information please contact journals.permissions@oup.com.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for
reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for
further information please contact journals.permissions@oup.com.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/39055581
Subjects
Blood pressure
Control
Hypertension
Nigeria
Screening
Treatment
Unaware
Publication Status
Published
Coverage Spatial
England
Article Number
suae053
Date Publish Online
2024-07-24